• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Wellington Partners

Sanofi et al. back €47m series-B for MinervaX
Sanofi et al. back €47m series-B for MinervaX

MinervaX has so far raised a total of $81.5m in funding, including grants

  • Early-stage
  • 16 December 2020
Wellington, HBM lead €22m round for Adrenomed
Wellington, HBM lead €22m round for Adrenomed

Round follows the company's €24m series-D in November 2019, also backed by Wellington and HBM

  • Early-stage
  • 01 December 2020
Longitude Capital leads $40m round for Polares Medical
Longitude Capital leads $40m round for Polares Medical

Existing investors Decheng, Endeavour Vision, IDO, Earlybird and Wellington also take part

  • Expansion
  • 25 June 2020
Wellington Partners makes seed investment in Sirs Therapeutics
Wellington Partners makes seed investment in Sirs Therapeutics

Life science and technology investor Wellington is the majority owner of the early-stage company

  • Early-stage
  • 15 April 2020
Immatics acquired by sponsor-backed Arya
Immatics acquired by sponsor-backed Arya

Immatics will receive proceeds of approximately $252m upon closing of the deal

  • Buyouts
  • 18 March 2020
Partech leads €30m series-B for Amboss
Partech leads €30m series-B for Amboss

Existing investors Cherry Ventures, Wellington Partners and Holtzbrinck Digital also take part

  • Expansion
  • 30 September 2019
VC firms back €20m series-A for Stipe
VC firms back €20m series-A for Stipe

Novo Holdings co-leads the round with Arix and Wellington Partners, and Sunstone Ventures invest

  • Early-stage
  • 30 September 2019
BtoV, Wellington and Seroba co-lead $48m series-C for Quanta
BtoV, Wellington and Seroba co-lead $48m series-C for Quanta

Existing investors BtoV, Wellington and Seroba all invested in the company's series-A in 2009

  • Early-stage
  • 29 July 2019
BioGeneration, Wellington lead €30m series-A for Confo
BioGeneration, Wellington lead €30m series-A for Confo

Fund+ and Perceptive Advisors, Capricorn, Qbic, PMV, Mints, V-Bio Ventures and VIB joined the round

  • Early-stage
  • 08 May 2019
VCs in $50m round for Onfido
VCs in $50m round for Onfido

Deal for the automated background check provider was led by the venture arms of SBI and Salesforce

  • Expansion
  • 04 April 2019
LSP in $50m series-A for Snipr Biome
LSP in $50m series-A for Snipr Biome

Lundbeckfonden Emerge invested an undisclosed sum in an exploratory investment in 2017

  • Early-stage
  • 12 March 2019
VC firms in $25m round for Polares Medical
VC firms in $25m round for Polares Medical

Earlybird Venture Capital, Wellington Partners and Endeavour Vision also take part

  • Early-stage
  • 18 July 2018
Wellington Partners et al. in €22m series-B for Tricares
Wellington Partners et al. in €22m series-B for Tricares

Investors back France-based Tricares, a specialist in tricuspid regurgitation treatment

  • Expansion
  • 04 June 2018
VC firms sell Invendo Medical to Ambu for €225m
VC firms sell Invendo Medical to Ambu for €225m

Selling shareholders include Xeraya, TVM, Wellington, 360 Capital and Heidelberg Innovation

  • Exits
  • 26 October 2017
VC firms back $58m series-E for Immatics
VC firms back $58m series-E for Immatics

Dievini Hopp Biotech holding, Wellington Partners, AT Impf and Amgen all invest in the round

  • Early-stage
  • 05 October 2017
Crane leads $30m series-C for Onfido
Crane leads $30m series-C for Onfido

Existing VC backers also took part in the round for the automated background check platform

  • Expansion
  • 28 September 2017
Balderton leads $7m series-A for Dalia
Balderton leads $7m series-A for Dalia

Backers include existing investors Wellington Partners and IBB-Bet

  • Expansion
  • 27 January 2017
Wellington Partners leads €14m financing round for UroMems
Wellington Partners leads €14m financing round for UroMems

Round includes €2m of funding from BPI France's PIA programme, adding to a €12m series-A

  • Expansion
  • 15 November 2016
MPM in iOmx Therapeutics' €40m series-A
MPM in iOmx Therapeutics' €40m series-A

Proceeds will be used to develop proprietary product candidates

  • Early-stage
  • 08 November 2016
Wellington, Seed Capital lead DKK 13m Tonsser series-A
Wellington, Seed Capital lead DKK 13m Tonsser series-A

International business angels also took part in the funding round

  • Early-stage
  • 10 June 2016
Endeavour et al. lead $25m series-D for Endostim
Endeavour et al. lead $25m series-D for Endostim

Endeavour Vision led the funding round alongside Gimv and Wellington Partners

  • Expansion
  • 13 May 2016
Gimv et al. lead €36m series-A for G-Therapeutics
Gimv et al. lead €36m series-A for G-Therapeutics

Listed buyout house Gimv invested €6m in the funding round led by LSP and Inkef

  • Early-stage
  • 19 April 2016
Idinvest et al. in $25m series-B for Onfido
Idinvest et al. in $25m series-B for Onfido

Automated background checking firm is to expand in the US after its rival's recent $40m round

  • Expansion
  • 14 April 2016
Oxford et al. in $13m round for Import.io

Other backers of the series-A include Imperial Innovations, Wellington Partners and Open Ocean

  • Expansion
  • 19 January 2016
123
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013